UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  February 17, 2005

 

NUVASIVE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-50744

 

33-0768598

(State or Other Jurisdiction of
Incorporation)

 

(Commission File
Number)

 

(I.R.S. Employer Idenitifcaiton
Number)

 

4545 Towne Centre Court, San Diego, California  92121

(Address of principal executive offices, with zip code)

 

(858) 909-1800

(Registrant’s telephone number, including area code)

 

n/a

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 2.02

Results of Operations and Financial Condition

 

 

On February 17, 2005, NuVasive, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2004. A copy of this press release is furnished as Exhibit 99.1 hereto.

 

 

Item 9.01

Financial Statements and Exhibits

 

 

(c)

Exhibits

 

 

Exhibit 99.1

Press release issued by NuVasive, Inc. on February 17, 2005, announcing financial results for the quarter and year ended December 31, 2004.

 

2



 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

NUVASIVE, INC.

 

 

 

 

Date:  February 17, 2005

By:

     /s/     KEVIN C. O’BOYLE

 

 

 

Kevin C. O’Boyle

 

 

Chief Financial Officer

 

3



 

EXHIBIT INDEX

 

 

Exhibit
Number

 

Description of Document

 

 

 

99.1

 

Press release issued by NuVasive, Inc. on February 17, 2005, announcing financial results for the quarter and year ended December 31, 2004.

 

4